| 305 |
abnormal |
signaling
(GO:0023052)
|
calmodulin
(PR:000004978)
|
1243: Altered, Ca2+-calmodulin activated signal transduction
|
| 222 |
abnormal |
|
capillary plexus
(UBERON:0035753)
|
298: Insufficiency, Vascular
|
| 171 |
increased |
signaling
(GO:0023052)
|
carbohydrate-responsive element-binding protein
(PR:000010460)
|
66: Activation, ChREBP
|
| 367 |
increased |
|
Carcinoma
(MESH:D002277)
|
10 Events
- 713: Increase, Adenomas/carcinomas (renal tubular)
- 719: Increase, hepatocellular adenomas and carcinomas
- 736: Increase, Adenomas/carcinomas (bronchioloalveolar)
- 741: Increase, Adenomas/carcinomas (follicular cell)
- 773: Increase, Endometrial adenocarcinomas
- 779: Increase, Papillomas/carcinomas (squamous cells)
- 797: Increase, Adenomas/carcinomas (urothelial)
- 1026: Increased Apoptosis, Adenomas/carcinomas (follicular cell)
- 1063: Increased, Pancreatic acinar tumors
- 1079: Increased, Adenomas/carcinomas (mammary)
|
| 19 |
decreased |
peptide secretion
(GO:0002790)
|
cardioactive peptide (fruit fly)
(PR:Q9VCW0)
|
1266: Decrease, Circulating crustacean cardioactive peptide
|
| 104 |
morphological change |
developmental process
(GO:0032502)
|
cardiovascular system
(UBERON:0004535)
|
None
|
| 495 |
abnormal |
cardiovascular system development
(GO:0072358)
|
cardiovascular system
(UBERON:0004535)
|
317: Altered, Cardiovascular development/function
|
| 251 |
decreased |
gene expression
(GO:0010467)
|
carnitine O-palmitoyltransferase 1, liver isoform
(PR:000005835)
|
472: Down Regulation, CPT1A
|
| 877 |
occurrence |
endocytosis involved in viral entry into host cell
(GO:0075509)
|
cathepsin L1 (human)
(PR:P07711)
|
1738: SARS-CoV-2 cell entry
|
| 752 |
decreased |
cell proliferation
(GO:0008283)
|
cell
(GO:0005623)
|
1821: Decrease, Cell proliferation
|
| 1091 |
increased |
cell death
(GO:0008219)
|
cell
(GO:0005623)
|
1825: Increase, Cell death
|
| 1106 |
abnormal |
cell differentiation
(GO:0030154)
|
cell
(GO:0005623)
|
1560: Cell differentiation, altered
|
| 701 |
disrupted |
regulation of cell cycle
(GO:0051726)
|
cell cycle-related cyclin
(PR:000029191)
|
1505: Increase, Cell cycle disruption
|
| 226 |
increased |
mutation
(MESH:D009154)
|
cellular tumor antigen p53
(PR:000003035)
|
376: Increased, Induced Mutations in Critical Genes
|
| 772 |
occurrence |
epithelial to mesenchymal transition
(GO:0001837)
|
cellular_component
(GO:0005575)
|
None
|
| 809 |
decreased |
|
cftr isoform 1
(PR:000001045)
|
None
|
| 854 |
increased |
chemokine secretion
(GO:0090195)
|
Chemokine
(FMA:241981)
|
1496: Increased, secretion of proinflammatory mediators
|
| 195 |
increased |
chemokine activity
(GO:0008009)
|
Chemokine
(FMA:241981)
|
151: Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways
|
| 14 |
increased |
chitin biosynthetic process
(GO:0006031)
|
chitin
(CHEBI:17029)
|
990: Increase, Incomplete ecdysis
|
| 49 |
decreased |
GABA-gated chloride ion channel activity
(GO:0022851)
|
chloride
(CHEBI:17996)
|
2 Events
|
| 399 |
increased |
chloride transmembrane transport
(GO:1902476)
|
chloride
(CHEBI:17996)
|
761: Increased, Chloride conductance
|
| 551 |
increased |
|
cholecystokinin
(PR:000005110)
|
1061: prolonged, elevation of serun CCK
|
| 129 |
occurrence |
|
cholestasis
(MESH:D002779)
|
2 Events
|
| 92 |
decreased |
mitochondrial transport
(GO:0006839)
|
cholesterol
(CHEBI:16113)
|
447: Reduction, Cholesterol transport in mitochondria
|
| 280 |
decreased |
cholesterol biosynthetic process
(GO:0006695)
|
cholesterol
(CHEBI:16113)
|
2 Events
|